Skip to content

VTVT

vTv Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$33.35
−0.36%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+4.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 29, 2026BAKER BROS. ADVISORS LP · directorA-Award6,000$35
Jun 29, 2026Phillips Anne M. · directorA-Award6,000$35
Jun 29, 2026Al-Marzooqi Fahed · directorA-Award6,000$35
Jun 29, 2026AKKARAJU SRINIVAS · directorA-Award6,000$35
Jun 29, 2026SPIEGELMAN DANIEL K · directorA-Award6,000$35
Feb 18, 2026Tung Michael Stephen · officer: EVP & CFOA-Award44,969$37
Feb 18, 2026SEKHRI PAUL J · director, officer: Pres, CEO and Exec ChairpersonA-Award140,000$37
Sep 25, 2025AKKARAJU SRINIVAS · directorA-Award106,000$15
Sep 25, 2025AKKARAJU SRINIVAS · directorA-Award877,214$0.01
Sep 25, 2025AKKARAJU SRINIVAS · directorA-Award983,214$23
Sep 5, 2025AKKARAJU SRINIVAS · directorA-Award655,523$0.01
Sep 5, 2025BAKER BROS. ADVISORS LP · directorA-Award2,353,913$0.01
Sep 5, 2025BAKER BROS. ADVISORS LP · directorA-Award2,400,605$0.00
Sep 5, 2025BAKER BROS. ADVISORS LP · directorA-Award217,144$0.01
Sep 5, 2025BAKER BROS. ADVISORS LP · directorA-Award221,452$0.00
Sep 5, 2025BAKER BROS. ADVISORS LP · directorA-Award46,692$15
Sep 5, 2025BAKER BROS. ADVISORS LP · directorA-Award4,308$15
Jun 12, 2025Al-Marzooqi Fahed · directorA-Award4,000$17
Jun 12, 2025BAKER BROS. ADVISORS LP · directorA-Award4,000$17
Jun 12, 2025SPIEGELMAN DANIEL K · directorA-Award4,000$17
Jun 12, 2025AKKARAJU SRINIVAS · directorA-Award4,000$17
Jun 12, 2025Phillips Anne M. · directorA-Award4,000$17
May 21, 2025Tung Michael Stephen · officer: EVP & CFOA-Award45,000$21
Apr 24, 2025AKKARAJU SRINIVAS · directorA-Award983$17
Apr 24, 2025AKKARAJU SRINIVAS · directorA-Award2,250$17
Mar 7, 2025SEKHRI PAUL J · director, officer: Pres, CEO and Exec ChairpersonA-Award108,000$20
Dec 6, 2024Samsara BioCapital GP, LLC · 10 percent ownerA-Award58,885$0.01
Dec 6, 2024AKKARAJU SRINIVAS · director, 10 percent owner: A-Award58,885$0.01
Nov 19, 2024SEKHRI PAUL J · director, officer: Pres, CEO and Exec ChairpersonPurchase1,844$17
Nov 19, 2024SEKHRI PAUL J · director, officer: Pres, CEO and Exec ChairpersonPurchase1,378$16
Institutional positioning

13F filings over the trailing two quarters

New 30Increased 12Reduced 13Sold out 6
FilerActionSharesFiled
Samsara BioCapital, LLCUnchanged298,496Aug 14, 2026
SAMSARA BIOCAPITAL, LLCUnchanged298,496May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased269,874Aug 14, 2026
FMR LLCReduced260,391May 15, 2026
FMR LLCUnchanged260,391Aug 13, 2026
MILLENNIUM MANAGEMENT LLCNew Position206,288May 15, 2026
SIREN, L.L.C.Unchanged163,000May 14, 2026
Siren, L.L.C.Unchanged163,000Aug 13, 2026
BAKER BROS. ADVISORS LPUnchanged148,314Aug 14, 2026
BAKER BROS. ADVISORS LPUnchanged148,314May 15, 2026
Trails Edge Capital Partners, LPReduced139,578May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position108,922May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCReduced94,463Aug 13, 2026
Trails Edge Capital Partners, LPReduced85,192Aug 14, 2026
Aisling Capital Management LPNew Position50,000Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 29, 2026